Table 1 Detailed information of 12 cases.
From: Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma
Case | Aetiology of infection | sex | Age | Max size (cm) | NAC | Tumour type | Differentiation | T | N | M | Stage (UICC 8th edition) | Vp, Vv, Va | Prognosis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FS1 | None | M | 79 | 1.8 | None | Mass forming type | Moderately | T1a | N0 | M0 | Stage IA | None | Alive without recurrence |
FS2 | None | M | 80 | 1.5 | None | Mass forming type | Moderately | T1a | N0 | M0 | Stage IA | None | Death |
KS1 | HBV + , HCV + | M | 67 | 12 | GS 2kur | Mass forming type | Moderately to poorly | T1b | N0 | M0 | Stage IB | None | Alive without recurrence |
KS2 | None | F | 79 | 3.5 | None | Mass forming and periductal infiltrating type | Well to moderately | T3 | N0 | M0 | Stage IIIA | Vp1 | Death |
KS3 | None | M | 67 | 6 | None | Mass forming type | Well to moderately | T2 | N1 | M1 | Stage IV | Vv2 | Death |
KS4 | None | F | 70 | 6 | GEM 3kur | Mass forming type | Well to moderately | T2 | N1 | M0 | Stage IIIB | None | Death |
KT1 | None | F | 64 | 5.4 | None | Mass forming type | Moderately | T1b | N0 | M0 | Stage IB | None | Alive without recurrence |
OK1 | None | M | 72 | 7.6 | None | Mass forming type | Well | T1b | N0 | M0 | Stage IB | None | Death |
OK2 | None | M | 78 | 4.4 | None | Mass forming type | Moderately | T2 | N0 | M0 | Stage II | Vp1 | Death |
OS1 | None | M | 76 | 8.8 | None | Mass forming type | Moderately | T2 | N1 | M0 | Stage IIIB | Vp1 | Death |
OS2 | None | F | 59 | 4.1 | GCS 3kur | Mass forming type | Moderately | T2 | N0 | M0 | Stage II | Vp1 | Alive without recurrence |
OS3 | None | M | 72 | 3.7 | None | Mass forming type | Well to poorly | T1a | N1 | M0 | Stage IIIB | none | Death |
